Furegrelate (sodium)


CAS No. : 85666-17-7

(Synonyms: U-63557A)

85666-17-7
Price and Availability of CAS No. : 85666-17-7
Size Price Stock
5mg $60 In-stock
10mg $100 In-stock
50mg $430 In-stock
100mg $690 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-106080A
M.Wt: 275.23
Formula: C15H10NNaO3
Purity: >98 %
Solubility: DMSO : 13 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 85666-17-7 :

Furegrelate Sodium (U-63557A) is a potent, orally available, and selective thromboxane synthase inhibitor. Furegrelate Sodium inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC50 of 15 nM. Furegrelate Sodium is being developed as an antiplatelet agent[1][2]. In Vivo:Furegrelate Sodium (1-5 mg/kg; po) prevents blockage of the coronary artery[1].
Furegrelate Sodium (0.1-5 mg/kg; i.v.) prevents the blockage of stenosed coronary arteries caused platelet aggregation[1].
Furegrelate Sodium blunts the development of hypoxia-induced pulmonary arterial hypertension (PAH) in an established neonatal piglet model primarily by preserving the structural integrity of the pulmonary vasculature[2].
Furegrelate has a long half-life compared to several other drugs used to treat PAH, including nitric oxide and prostagcyclin analogues; And Furegrelate is highly specific to the target enzyme[2].

Your information is safe with us.